.
Young cancer patient's good news: 'Total remission!'
The seventh child to receive an experimental leukemia therapy at Children's Hospital of Philadelphia got good news last week: It worked.
"Avrey Walker is cancer free!!!! A total remission!" her father, Aaron, exulted on their Facebook page.
The 9-year-old from Redmond, Ore., was diagnosed at age 4 with acute lymphoblastic leukemia, a blood cancer that can be deadly within a few months if not treated.
Like other children in the study at Children's, Avrey had undergone years of intermittent chemotherapy, only to relapse each time the toxic treatments ended.
She was one of the minority of children who do not respond to conventional treatments. Today, with potent chemotherapies and radiation, about 80 percent of the 3,000 children diagnosed annually in the United States are cured. But the treatments are harsh, and when they fail, the options are increasingly grim.
Aaron Walker and his wife, Christal, turned to Children's after reading about Emily Whitehead of Philipsburg, Pa., the first child to receive the hospital's genetically engineered therapy, made using each patient's disease-fighting "T cells." Emily remains in remission, a year after treatment.
Avrey and her parents spent about 50 days in Philadelphia while her T cells were modified, multiplied, and, a month ago, returned to her bloodstream.
"I have heard of miracles like most of us have; however I have never witnessed one in person - until now," Walker said. "We are so thankful!"
The immunotherapy researchers, including Stephan Grupp at Children's and Carl H. June at the University of Pennsylvania, recoil from words like miracle. And they have published results from only the first two children.
Still, the T-cell therapy is showing startling effectiveness, judging from both scientific and parental accounts: Of the first seven children, five had a complete response - no evidence of cancer - although one of them later relapsed. One child did not respond, and one child's outcome has not been made public by parents or doctors.
The therapy involves transferring genes into T cells - the soldiers of the immune system - to make them recognize and attack B cells, the blood component that turns malignant in certain leukemias and lymphomas. There is also evidence that some of the designer T cells develop immune "memory," so they could reactivate and strike if cancer returns.
Recently, this immunotherapy technology has been successfully used in small numbers of patients in studies at Sloan-Kettering Memerial Cancer Center in New York and the National Cancer Institute in Bethesda, Md.
The toxicity of this new approach is not yet clear, and seems to vary. At one extreme, Emily Whitehead nearly died when the T cells threw her immune system into overdrive. Avrey's reaction, in contrast, was unusually mild.
"We were all waiting for the big storm," her father said. "She just felt a little groggy and had a low-grade fever" for about a day.
The durability of the therapeutic effect is also unclear. However, an adult leukemia patient treated at Penn remains cancer-free two and a half years after treatment.
Children like Avrey have never known such a lengthy respite from disease, disability, and dread. Now, her father said, she wants to go back to fourth grade, play softball, hang out with her big sister, Madison.
"We'll try to get back to a normal life," he said, "something we haven't had for 10 years."
Contact Marie McCullough at 215-854-2720 or mmccullough@phillynews.com.
"Avrey Walker is cancer free!!!! A total remission!" her father, Aaron, exulted on their Facebook page.
The 9-year-old from Redmond, Ore., was diagnosed at age 4 with acute lymphoblastic leukemia, a blood cancer that can be deadly within a few months if not treated.
Like other children in the study at Children's, Avrey had undergone years of intermittent chemotherapy, only to relapse each time the toxic treatments ended.
She was one of the minority of children who do not respond to conventional treatments. Today, with potent chemotherapies and radiation, about 80 percent of the 3,000 children diagnosed annually in the United States are cured. But the treatments are harsh, and when they fail, the options are increasingly grim.
Aaron Walker and his wife, Christal, turned to Children's after reading about Emily Whitehead of Philipsburg, Pa., the first child to receive the hospital's genetically engineered therapy, made using each patient's disease-fighting "T cells." Emily remains in remission, a year after treatment.
Avrey and her parents spent about 50 days in Philadelphia while her T cells were modified, multiplied, and, a month ago, returned to her bloodstream.
"I have heard of miracles like most of us have; however I have never witnessed one in person - until now," Walker said. "We are so thankful!"
The immunotherapy researchers, including Stephan Grupp at Children's and Carl H. June at the University of Pennsylvania, recoil from words like miracle. And they have published results from only the first two children.
Still, the T-cell therapy is showing startling effectiveness, judging from both scientific and parental accounts: Of the first seven children, five had a complete response - no evidence of cancer - although one of them later relapsed. One child did not respond, and one child's outcome has not been made public by parents or doctors.
The therapy involves transferring genes into T cells - the soldiers of the immune system - to make them recognize and attack B cells, the blood component that turns malignant in certain leukemias and lymphomas. There is also evidence that some of the designer T cells develop immune "memory," so they could reactivate and strike if cancer returns.
Recently, this immunotherapy technology has been successfully used in small numbers of patients in studies at Sloan-Kettering Memerial Cancer Center in New York and the National Cancer Institute in Bethesda, Md.
The toxicity of this new approach is not yet clear, and seems to vary. At one extreme, Emily Whitehead nearly died when the T cells threw her immune system into overdrive. Avrey's reaction, in contrast, was unusually mild.
"We were all waiting for the big storm," her father said. "She just felt a little groggy and had a low-grade fever" for about a day.
The durability of the therapeutic effect is also unclear. However, an adult leukemia patient treated at Penn remains cancer-free two and a half years after treatment.
Children like Avrey have never known such a lengthy respite from disease, disability, and dread. Now, her father said, she wants to go back to fourth grade, play softball, hang out with her big sister, Madison.
"We'll try to get back to a normal life," he said, "something we haven't had for 10 years."
Contact Marie McCullough at 215-854-2720 or mmccullough@phillynews.com.
Subscribe to:
Post Comments
(Atom)
Business owners Sign up here for Free
Can You Have More Sales, Too?
Helping over 120,000+ businesses like yours raise profits and build customer relationships using AWeber's opt-in email marketing software for over 10 years.
Liked what you read? Have it delivered to your email by signing up here: http://bit.ly/pellaumagsubscribe
Trending Articles This Week
-
Click here to share us on facebook! Congratulations to Soca star Kees Dieffenthaller, who wed his longtime girlfriend Teri Leigh Bove...
-
This is the video everyone is talking about. What do you think about it? Is it as horrible as everyone describes? Click ...
-
Well we waited for what seems like forever since Finding Nemo first aired back in 2003! How will Finding Dory stack up? Only time will tell...
-
And the Kim Kardashian revelations just keep on coming from Miz Myla Sinanaj! According to the other ex of Kris Humphries, he knew that th...
-
Four years after she was assaulted by boyfriend Chris Brown , Rihanna says she's ready to rekindle their friendship. In the April...
-
POS, Trinidad (Sonique Solutions) – As the days countdown to the greatest show on Earth new music for the relatively short season seems to c...
-
Web 3 new results for hollywood Kim Kardashian To Get Married To Kris Humphries ... - Hollywood Life Kim Kardashian and Kris Humphries...
-
News 5 new results for hollywood Detroit's Coney Dog premieres in West Hollywood Detroit Free Press BY KELLEY L. CARTER WEST HOLLYWOO...
-
News 2 new results for pop music Music review: Opening night at the Hollywood Bowl Los Angeles Times Estefan likewise mines a deep cultu...
-
P.O.S, Trinidad ( Sonique Solutions ) – Trinidad and Tobago based entertainment management group Ask Promotions will be undertaking the...
Liked what you read? Have it delivered to your email by signing up here: http://bit.ly/pellaumagsubscribe
Pellau Magazine. Powered by Blogger.
Disclaimer
THIS SITE CLAIMS NO CREDIT FOR ANY CONTENT FEATURED ON THIS BLOG UNLESS OTHERWISE NOTED. ALL VISUAL CONTENT IS COPYRIGHT TO IT'S RESPECTFUL OWNERS, I.E WRITERS/PHOTOGRAPHERS INDICATED PER POST. IF YOU OWN THE RIGHTS TO ANY OF THE CONTENT AND DO NOT WISH THEM TO APPEAR ON THIS BLOG PLEASE CONTACT US, PROOF INCLUDED AND THEY WILL BE PROMPTLY REMOVED.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
0 comments:
Post a Comment